ClinicalTrials.Veeva

Menu

Metabolic Profile of Users of Hormonal and Non-hormonal Contraceptives

F

Federal University of São Paulo

Status

Completed

Conditions

Contraceptive Usage
Body Weight Changes
Metabolic Syndrome

Treatments

Drug: Combined Oral Contraceptive
Device: Intrauterine device
Drug: Depot-Medroxyprogestereone Acetate
Drug: Progestin-only pills

Study type

Observational

Funder types

Other

Identifiers

NCT03383185
CAAE: 45523715.4.0000.5505

Details and patient eligibility

About

Evaluation of metabolic profile of users of hormonal and non-hormonal contraceptives during five years follow-up

Full description

Were eligible for the study 489 Women, followed in Federal University of São Paulo Family Planning Service, who used the same contraceptive method during five year of follow-up, According to the service protocol, the patients, after had participated of a orientation group about contraceptives methods, elected one of them. After that, if the choice had been according to the eligibility criteria of World Health Organization, it was approved by a gynecologist.

The contraceptive methods available were the intrauterine device (IUD) oral contraceptives, including combined pills and progestin-only formulations, and depot medroxyprogestereone acetate.

The study consisted in the evaluation of their medical records of weight, BMI, Blood pressure, glycemia, seric levels of cholesterol and triglycerides, during the five years, and in the comparison of the differences of these data between the contraceptive methods.

Enrollment

489 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • women in reproductive age followed in Federal university of Sao Paulo Family Planning Service
  • use of the same contraceptive method during five years

Exclusion criteria

  • incomplete data

Trial design

489 participants in 2 patient groups

Non-hormonal contraceptive
Description:
Users of non- hormonal intrauterine device during the 5 years follow-up
Treatment:
Device: Intrauterine device
Hormonal contraceptives
Description:
Users of combined oral contraceptive, progestin-only pills, depot-medroxyprogestereone acetate during 5 years follow-up
Treatment:
Drug: Combined Oral Contraceptive
Drug: Depot-Medroxyprogestereone Acetate
Drug: Progestin-only pills

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems